LICENSE AND DEVELOPMENT AGREEMENT WITH BLISS BIOPHARMACEUTICAL (HANGZHOU) CO. LTD.*License and Development Agreement • September 18th, 2018
Contract Type FiledSeptember 18th, 2018This announcement is made by the board (the “Board”) of directors (the “Directors”) of Genscript Biotech Corporation (the “Company”, together with its subsidiaries, the “Group”) pursuant to Rule 13.09 of the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited (the “Listing Rules”) and the Inside Information Provisions (as defined in the Listing Rules) under Part XIVA of the Securities and Futures Ordinance (Chapter 571 of the Laws of Hong Kong).